Editor of Patient Care Online.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of March 7, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of March 4, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of March 3, 2022
New CDC COVID-19 Community Level Metrics: Questions Patients May Have, Answers to Prep Clinicians
What questions might patients have about the CDC's new framework to measure COVID-19 community levels? Prep with our new slideshow.
Largest Genetic Study of Migraine to Date Identifies New Risk Factors
Researchers identified over 120 regions connected to risk of migraine, of which 86 were previously unknown.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of March 2, 2022
CDC: Americans Living in Low- or Medium-Risk Areas Can Leave Mask at Home
Approximately 70% of Americans live in areas deemed low or medium risk for severe COVID-19 and can go maskless, according to new formula used by CDC.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of March 1, 2022
Migraine Linked to Higher Risk of Pregnancy Complications in Preliminary Study
Researchers also found that women with migraine with aura had a higher risk of preeclampsia than those with migraine without aura.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 28, 2022
Mepolizumab Clinically Effective Regardless of Type 2 Biomarker Status in Patients with Severe Asthma, Suggests Real-world Data
AAAAI 2022: Mepolizumab found effective in standard clinical care regardless of type 2 eosinophil biomarker status in patients with severe asthma.
Dupilumab Found to Improve Clinical, Histologic Aspects of Eosinophilic Esophagitis
AAAAI 2022: New study found patients with eosinophilic esophagitis who received dupilumab experienced clinically meaningful improvements in symptoms.
Dupilumab Significantly Decreased Itch and Hives in Patients with Chronic Spontaneous Urticaria
Dupilumab significantly reduced itch and hives in patients with H1 antihistamine-resistant chronic spontaneous urticaria, according to new research.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 25, 2022
Fostering Wellbeing in School-aged Children during COVID-19
How can clinicians help parents of school-aged children foster wellbeing now that pediatric COVID-19 vaccination and booster doses are recommended?
Sexual Assault, Workplace Harassment Raises Hypertension Risk in Middle-aged Women
A study of midlife women found those with a history of both sexual assault and workplace sexual harassment had the highest risk of hypertension.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 24, 2022
COVID-19 vs Influenza: 7 Questions on What Makes Them Different
From transmission to treatment, COVID-19 and flu have several similarities and differences. Knowing how they differ will be the key to diagnosis this flu season.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 23, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 22, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 21, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 18, 2022
Poor Sleep Linked to Increased Risk of Cardiovascular Disease in Middle Adulthood
New study showed adults who provided sleep health data and wore a research device during sleep had a 141% increased risk of cardiovascular disease.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 17, 2022
Tezepelumab Reduced Number of Symptomatic Days in Adults and Children with Severe, Uncontrolled Asthma
Patients with severe, uncontrolled asthma given tezepelumab experienced a reduction in asthma symptomatic days, found a new analysis of the NAVIGATOR trial.
NOACs Linked to Lower Risk for Vascular Issues than Warfarin in Patients with Diabetes, Atrial Fibrillation
Researchers in Taiwan found NOACs were associated with lower hazards of diabetes complications. and death than warfarin in persons with AF and DM.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 16, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 15, 2022
Study: Poor Outcomes Linked to Cannabis Use in Patients with Cerebrovascular Diagnoses
Marijuana use is linked to increased perioperative mortality among patients admitted to the hospital for cerebrovascular diagnoses, according to research presented at ISC 2022.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 14, 2022
